CL-860201

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCL-860201

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmersham

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmersham

Active IndicationsN/A

Inactive IndicationsHeart Failure

ATC CodeN/A